NCCRED is opening a competitive round of seed funding grants to support innovative clinical research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern.

Focus of the funding round

The current funding round aims is to provide financial support in the form of:

1. Seed-funding grants to establish investigator-initiated clinical research; or
2. A value-add to research projects that are currently underway.

Projects must relate to methamphetamine or emerging drugs of concern and preference will be given to projects that address the research priorities outlined in the NCCRED seed funding round 4 guidelines and application form below.

Importantly, applicants are encouraged to apply for funding that will enable a study to:

• Answer relevant clinical questions
• Build research capacity
• Produce translational research results (see criteria below for more details)

The grant should produce a fundable project that has the capacity to attract further funding (as required).

Key Dates

Applications open 18 Feb 21
Applications close 14 Apr 21
Applications reviewed by the NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group 11 May 21
NCCRED Board awards funding 17 May 21
Applicants are notified of results 18 May 21
Final study report due to NCCRED 10 Jun 22

For more information, please visit the NCCRED website here.